Telogen Effluvium

    Wizar Putri Mellaratna, Vina Zaynah Kholilullah
    Image of study
    TLDR Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.
    Telogen effluvium is a condition characterized by the premature shedding of hair in the telogen phase, caused by trauma to normal hair due to stimuli that accelerate the transition from the anagen to the catagen and telogen phases. The incidence or prevalence of telogen effluvium is unclear. It can occur in both men and women and can be caused by various factors, including psychological stress, acute fever, malnutrition, pregnancy, systemic diseases, and medication. Diagnosis of telogen effluvium can be established through anamnesis, physical examination, and supporting examinations. Proper management requires time to identify the cause of hair loss and its treatment. The most important aspect is providing information and education to patients about the course of their disease.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 616 results

      community My scalp punch biopsy results🤔?

      in Female  9 upvotes 2 years ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

      community Switch from fin to dut and its worse

      in Finasteride/Dutasteride  7 upvotes 5 months ago
      Switching from finasteride to dutasteride can worsen hair loss for some men due to increased testosterone levels. Topical treatments like RU58841 and Pyrilutamide are suggested to counteract these effects, but individual responses vary.

      community My Theory Of Androgenic Alopecia

      in Research/Science  16 upvotes 2 days ago
      Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Similar Research

    6 / 1000+ results